Acute pancreatitis (diagnostic tests)

Under construction / Forgotten

This article was marked by its author as Under construction, but the last edit is older than 30 days. If you want to edit this page, please try to contact its author first (you fill find him in the history). Watch the discussion as well. If the author will not continue in work, remove the template {{Under construction}} and edit the page. Last update: Sunday, 29 Nov 2020 at 11.13 pm.

This article has been translated from WikiSkripta; the translation needs to be checked.

This article has been translated from WikiSkripta; the formatting needs to be checked.

This article has been translated from WikiSkripta; ready for the editor's review.

thumb|Akutní pankreatitida, patogenetické sekvence Acute pancreatitis (AP) is a disease with variable clinical manifestations. The various prognostic criteria include early diagnosis, disease severity and monitoring the course of the disease.

Two stages of severe cases of AP are differentiated:

• The first stage is extensive inflammation of the pancreas, possibly necrotizing, with the subsequent development of systemic inflammatory response syndrome - SIRS which can lead to multiple organ dysfunction syndrome - MODS with symptoms and complications similar to polytrauma, sepsis and burns.
• The next stage is marked by necrosis (often caused by bacterial infection) and by worsening of systemic complications, renal failure, coagulation disorders and other.

Iron

Diagnostic tests

thumb|Rutinní dg stanovení pankreatických enzymů Diagnostic tests include assessment of a wide range of specific and non-specific markers, pancreatic enzymes and their precursors in serum or urine, inflammatory markers and markers of immune responses - cytokinesgg, interleukins, TNF.

Total serum amylase is most commonly used for diagnosis, it is usually elevated with the onset of AP and returns to normal within 3-5 days. Levels of α-amylase is always elevated in 100 % of the cases of AP, but it is also elevated in 80 % of the cases of abdominal pains.

Assesment of pancreatic isoenzyme (P-type of α-amylase = P-AMS) in serum is more beneficial for diagnosis, because it is also elevated in 100 % of the cases of AP, but only in 10 % of abdominal pains. Lipase and pancreatic elastase-1 are also reliable markers.

Assessment of activation peptides TAP a CAPAP levels in urine are most commonly used as reliable markers for fast diagnosis. Serum procalcitonin levels are studied in the last few years as markers for bacterial infection of pancreatic necrosis and sepsis.

Links

Related articles

• Acute pancreatitis
• Chronic pancreatitis
• Chronic pancreatitis (diagnostic tests)

Sources

• with the permission of the author taken from KOCNA, Petr. GastroLab : MiniEncyklopedie laboratorních metod v gastroenterologii [online]. ©2002. The last revision 2011-01-08, [cit. 2011-03-04]. <http://www1.lf1.cuni.cz/~kocna/glab/glency1.htm>.

Literature

• SKIPWORTH, JR. , et al. Acute pancreatitis. Curr Opin Crit Care. 2008, vol. 14, no. 2, p. 172-8, ISSN 1070-5295 (Print), 1531-7072 (Electronic). PMID: 18388680.

• KIM, YS. , et al. Is there correlation between pancreatic enzyme and radiological severity in acute pancreatitis?. World J Gastroenterol. 2008, vol. 14, no. 15, p. 2401-5, ISSN 1007-9327. PMID: 18416469.

• CARROLL, JK. , et al. Acute pancreatitis: diagnosis, prognosis, and treatment. Am Fam Physician. 2007, vol. 75, no. 10, p. 1513-20, ISSN 0002-838X (Print), 1532-0650 (Electronic). PMID: 17555143.

• KAPETANOS, D. , et al. The value of serum amylase and elastase measurements in the prediction of post-ERCP acute pancreatitis. Hepatogastroenterology. 2007, vol. 54, no. 74, p. 556-60, ISSN 0172-6390. PMID: 17523321.

• PURKAYASTHA, S. , et al. Does serum procalcitonin have a role in evaluating the severity of acute pancreatitis? A question revisited. World J Surg. 2006, vol. 30, no. 9, p. 1713-21, ISSN 0364-2313 (Print), 1432-2323 (Electronic). PMID: 16927057.

• MATULL, WR. , et al. Biochemical markers of acute pancreatitis. J Clin Pathol. 2006, vol. 59, no. 4, p. 340-4, ISSN 0021-9746 (Print), 1472-4146 (Electronic). PMID: 16567468.

• AL-BAHRANI, AZ. , et al. Clinical laboratory assessment of acute pancreatitis. Clin Chim Acta. 2005, vol. 362, no. 1-2, p. 26-48, ISSN 0009-8981 (Print), 1873-3492 (Electronic). PMID: 16024009.

• PAPACHRISTOU, GI. , et al. Inflammatory markers of disease severity in acute pancreatitis. Clin Lab Med. 2005, vol. 25, no. 1, p. 17-37, ISSN 0272-2712 (Print), 1557-9832 (Electronic). PMID: 15749230.

• RICHÉ, FC. , et al. Inflammatory cytokines, C reactive protein, and procalcitonin as early predictors of necrosis infection in acute necrotizing pancreatitis. Surgery. 2003, vol. 133, no. 3, p. 257-62, ISSN 0039-6060 (Print), 1532-7361 (Electronic). PMID: 12660636.

• SMOTKIN, J. , et al. Laboratory diagnostic tests in acute pancreatitis. J Clin Gastroenterol. 2002, vol. 34, no. 4, p. 459-62, ISSN 0192-0790 (Print), 1539-2031 (Electronic). PMID: 11907364.

• MÁNDI, Y. , et al. Diagnostic relevance of procalcitonin, IL-6, and sICAM-1 in the prediction of infected necrosis in acute pancreatitis. Int J Pancreatol. 2000, vol. 28, no. 1, p. 41-9, ISSN 0169-4197. PMID: 11185709.